Cargando…
Pharmacologic Approaches Against Advanced Glycation End Products (AGEs) in Diabetic Cardiovascular Disease
CONTEXT: Advanced Glycation End-Products (AGEs) are signaling proteins associated to several vascular and neurological complications in diabetic and non-diabetic patients. AGEs proved to be a marker of negative outcome in both diabetes management and surgical procedures in these patients. The report...
Autores principales: | Nenna, Antonio, Nappi, Francesco, Avtaar Singh, Sanjeet Singh, Sutherland, Fraser W., Di Domenico, Fabio, Chello, Massimo, Spadaccio, Cristiano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571620/ https://www.ncbi.nlm.nih.gov/pubmed/26393232 http://dx.doi.org/10.5812/cardiovascmed.4(2)2015.26949 |
Ejemplares similares
-
Targeting Advanced Glycation End Products in Cardiac Surgery: The Unexplored Alternative
por: Nenna, Antonio, et al.
Publicado: (2016) -
Impact of Mitral Regurgitation Recurrence on Mitral Valve Repair for Secondary Ischemic Mitral Regurgitation
por: Salsano, Antonio, et al.
Publicado: (2023) -
The Use of Bioactive Polymers for Intervention and Tissue Engineering: The New Frontier for Cardiovascular Therapy
por: Nappi, Francesco, et al.
Publicado: (2021) -
The Use of the Cryopreserved Aortic Homograft for Aortic Valve Replacement: Is It Still an Option?
por: Nappi, Francesco, et al.
Publicado: (2023) -
Revisiting the guidelines and choice the ideal substitute for aortic valve endocarditis
por: Nappi, Francesco, et al.
Publicado: (2020)